002317SZSE

Independent Director's 2025 Annual Performance Report (Jiang Baiguo)

✨ AI Summary

This report details the performance of Independent Director Jiang Baiguo for 2025. He attended all required meetings, exercised independent judgment on all proposals, and confirmed no conflicts of interest. The company provided adequate support for his duties, and he focused on compliance and risk prevention, protecting minority shareholder interests.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Independent Director's 2025 Annual Performance Report

To all shareholders and shareholder representatives:

As an independent director of Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "Zhongsheng Pharmaceutical"), in accordance with relevant laws, regulations such as the "Company Law," "Administrative Measures for Independent Directors of Listed Companies," and the "Articles of Association" and "Work System for Independent Directors," I have faithfully and diligently performed my duties, fully utilized the role of an independent director, and protected the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders.

Here is my report on the performance of my duties as an independent director for 2025:

I. Basic Information

(I) Work Experience, Professional Background, and Concurrent Positions

I am Jiang Baiguo, with a Ph.D. from Southwest University of Political Science and Law. I previously served as an assistant lecturer, lecturer, associate professor, and professor at South China Agricultural University, and as the Director of the Law Department of the School of Humanities and Law at South China Agricultural University. I am currently a professor at the School of Law, Guangdong University of Foreign Studies and Trade. I was elected as an independent director of Zhongsheng Pharmaceutical's Ninth Board of Directors on December 29, 2025.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.